✦ LIBER ✦

304 – Efficacy of bifeprunox in patients in the post-acute, maintenance phase of schizophrenia: Findings from a 6-month study

✍ Scribed by M. Bourin; M. Debelle; J. Heisterberg; M. Krog Josiassen; J. Buch Østergaard; E. Sands

Book ID: 119363727
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 98
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2007.12.371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.052 Long-term efficacy and safety

P.3.c.052 Long-term efficacy and safety of bifeprunox in stable patients with schizophrenia: findings from a 6-month study

✍ M. Bourin; M. Debelle; J. Heisterberg; M. Krog Josiassen; J. Buch Østergaard; E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Efficacy and safety of bifeprunox in pat

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study

✍ Daniel E. Casey; Earl E. Sands; Jens Heisterberg; Hwa-Ming Yang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

Su2080 Efficacy of Budesonide MMx(r) 6 m

Su2080 Efficacy of Budesonide MMx(r) 6 mg QD for the Maintenance of Remission in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study

✍ Sandborn, William J.; Danese, Silvio; Ballard, E. David; Moro, Luigi; Jones, Ric 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Efficacy of iloperidone in the short-ter

Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials

✍ Leslie Citrome; Xiangyi Meng; Marla Hochfeld; Stephen M Stahl 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

## Objectives The efficacy and tolerability characteristics of an antipsychotic are difficult to determine from a single registration study. We thus conducted an analysis that assessed key efficacy and tolerability outcomes __post hoc__ from four pooled short‐term (4–6 weeks) phase III studies that

Su2088 Safety Analysis of Budesonide MMx

Su2088 Safety Analysis of Budesonide MMx 6 mg Used for the Maintenance of Remission in Patients With Ulcerative Colitis: Results From a Phase III, 12 Month Safety and Extended use Study

✍ Travis, Simon; Danese, Silvio; Ballard, E. David; Moro, Luigi; Jones, Richard J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 250 KB

The Effect of Baseline Testosterone on t

The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients

✍ Jan-Erik Damber; Teuvo L.J. Tammela; Peter Iversen; Per-Anders Abrahamsson; Laur 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 358 KB